Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Nov 4;31(1):210–220. doi: 10.1158/1055-9965.EPI-21-0463

Table 3.

Presence of F nucleatum subspecies in colorectal cancer tissue and CRC-specific survival.

F nucleatum subsp
animalis
cases
(n)
events
(n)
aHR (95% CI) bHR (95% CI)
Negative 1196 224 1.00 (reference) 1.00 (reference)
animalis 80 20 2.16 (1.34-3.47) 1.75 (0.99- 3.10)
p-value 0.0016 0.056
vincentii + nucleatum 40 6 1.07 (0.48-2.43) 1.02 (0.42-2.51)
p-value 0.86 0.96

HR = Hazard Ratio, CI = Confidence Interval

a

multivariable analysis adjusted for sex, age at diagnosis, tumor site, hypermutation status, tumor burden, mutations in POLE, TP53, and ERBB3, and MSI status

b

multivariable analysis adjusted for sex, age at diagnosis, tumor site, hypermutation status, tumor burden, mutations in POLE, TP53, and ERBB3, and MSI status, and tumor stage